Evolent Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Evolent Health
EVH Stock  USD 12.21  0.96  8.53%   
Evolent Health financial statements provide useful quarterly and yearly information to potential Evolent Health investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Evolent Health financial statements helps investors assess Evolent Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Evolent Health's valuation are summarized below:
Gross Profit
316.6 M
Profit Margin
(0.03)
Market Capitalization
1.3 B
Enterprise Value Revenue
0.7437
Revenue
2.5 B
We have found one hundred twenty available fundamental signals for Evolent Health, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Evolent Health prevailing fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year. Enterprise Value is estimated to decrease to about 742.8 M

Evolent Health Total Revenue

2.06 Billion

Check Evolent Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolent Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 129.6 M, Total Revenue of 2.1 B or Gross Profit of 483.5 M, as well as many indicators such as Price To Sales Ratio of 1.78, Dividend Yield of 0.0072 or PTB Ratio of 3.61. Evolent financial statements analysis is a perfect complement when working with Evolent Health Valuation or Volatility modules.
  
Check out the analysis of Evolent Health Correlation against competitors.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

Evolent Health Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.8 B2.7 B1.1 B
Slightly volatile
Other Current Liabilities630.6 M600.5 M176.7 M
Slightly volatile
Total Current Liabilities708 M674.2 M226 M
Slightly volatile
Property Plant And Equipment Net84.7 M90.2 M63.5 M
Slightly volatile
Accounts Payable48.9 M48.2 M39.1 M
Slightly volatile
Cash176.4 M192.8 M140.7 M
Slightly volatile
Non Current Assets Total2.1 B2 B812.2 M
Slightly volatile
Other Assets60.4 M33 M48.3 M
Slightly volatile
Cash And Short Term Investments196.3 M192.8 M155 M
Slightly volatile
Net Receivables469.1 M446.7 M116.8 M
Slightly volatile
Common Stock Shares Outstanding70.4 M111.3 M55.9 M
Slightly volatile
Liabilities And Stockholders Equity2.8 B2.7 B1.1 B
Slightly volatile
Other Current Assets73.6 M44.1 M58.5 M
Slightly volatile
Total Liabilities1.7 B1.6 B508.1 M
Slightly volatile
Total Current Assets354.3 M683.7 M282.4 M
Slightly volatile
Intangible Assets789.6 M752 M256.5 M
Slightly volatile
Other Liabilities71.7 M63.8 M53.2 M
Slightly volatile
Current Deferred Revenue5.7 M6 M15 M
Slightly volatile
Short Term Investments25.7 M13.8 M18.9 M
Slightly volatile
Non Current Liabilities Total985.3 M938.4 M287.3 M
Slightly volatile
Property Plant And Equipment Gross139.8 M248.7 M97.8 M
Slightly volatile
Short Term Debt18.5 M19.5 M50.7 M
Very volatile
Property Plant Equipment60.1 M101.1 M50 M
Slightly volatile
Good Will707.6 M1.1 B638.4 M
Pretty Stable
Common Stock Total Equity791.4 K1.2 M562.5 K
Slightly volatile
Deferred Long Term Liabilities4.1 M4.3 M12.9 M
Slightly volatile
Long Term Investments4.7 M4.9 M28.5 M
Pretty Stable
Common Stock839.2 K1.2 M564.8 K
Slightly volatile
Noncontrolling Interest In Consolidated Entity5.7 M6 M136 M
Slightly volatile
Capital Surpluse1.1 B1.7 B845.7 M
Slightly volatile
Non Current Liabilities Other3.5 M3.6 M25.6 M
Slightly volatile
Short and Long Term Debt Total373.3 M644.8 M254 M
Slightly volatile
Long Term Debt Total259 M474.9 M206.9 M
Slightly volatile
Short and Long Term Debt22.7 M23.9 M76.2 M
Slightly volatile
Cash And Equivalents231.9 M216.4 M182.1 M
Slightly volatile
Net Invested Capital1.3 B1.7 B1.2 B
Slightly volatile
Net Working Capital9 M9.4 M167 M
Slightly volatile
Capital Stock1 M1.2 M881.1 K
Slightly volatile
Capital Lease Obligations51.3 M47.7 M69.9 M
Slightly volatile

Evolent Health Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization129.6 M123.4 M41.9 M
Slightly volatile
Total Revenue2.1 B2 B648 M
Slightly volatile
Other Operating Expenses2.1 B2 B689.1 M
Slightly volatile
Cost Of Revenue1.6 B1.5 B462.4 M
Slightly volatile
Selling General Administrative236.7 M358.1 M176.7 M
Slightly volatile
Research Development16.2 M26.7 M12.3 M
Slightly volatile
Non Recurring197.3 M247.4 M187.6 M
Slightly volatile
Interest Income4.9 M5.3 M13.3 M
Slightly volatile
Reconciled Depreciation70.7 M123.4 M49.8 M
Slightly volatile

Evolent Health Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation42.5 M40.5 M17 M
Slightly volatile
Begin Period Cash Flow229 M215.2 M175.8 M
Slightly volatile
Depreciation129.6 M123.4 M40.8 M
Slightly volatile
Capital Expenditures24.8 M28.7 M20 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.781.87113.4543
Pretty Stable
Dividend Yield0.00720.00510.012
Slightly volatile
Days Sales Outstanding76.6283.030673.7918
Slightly volatile
Stock Based Compensation To Revenue0.01960.02060.0413
Pretty Stable
Capex To Depreciation0.220.23295.1268
Slightly volatile
Payables Turnover32.7231.161711.5945
Slightly volatile
Sales General And Administrative To Revenue0.550.280.5107
Slightly volatile
Average Inventory0.40.450.49
Slightly volatile
Research And Ddevelopement To Revenue0.03970.0230.0454
Slightly volatile
Capex To Revenue0.01390.01460.1148
Slightly volatile
Cash Per Share1.651.733264.4924
Slightly volatile
Days Payables Outstanding11.1311.713160.9892
Slightly volatile
Intangibles To Total Assets0.390.69710.4333
Slightly volatile
Current Ratio1.991.0141.6788
Very volatile
Receivables Turnover4.884.3965.6341
Slightly volatile
Graham Number14.0714.8125576
Slightly volatile
Debt To Equity0.60.56830.2863
Slightly volatile
Capex Per Share0.280.25840.3297
Pretty Stable
Revenue Per Share16.7717.6528106
Slightly volatile
Interest Debt Per Share6.245.94142.3332
Slightly volatile
Debt To Assets0.140.22640.1396
Slightly volatile
Days Of Payables Outstanding11.1311.713160.9892
Slightly volatile
Long Term Debt To Capitalization0.180.35860.1955
Slightly volatile
Total Debt To Capitalization0.190.36240.1991
Slightly volatile
Debt Equity Ratio0.60.56830.2863
Slightly volatile
Quick Ratio0.961.0141.8554
Pretty Stable
Net Income Per E B T0.920.55850.8696
Slightly volatile
Cash Ratio0.270.2861.0653
Slightly volatile
Days Of Sales Outstanding76.6283.030673.7918
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.460.79841.7147
Pretty Stable
Fixed Asset Turnover22.8721.77828.1717
Slightly volatile
Debt Ratio0.140.22640.1396
Slightly volatile
Price Sales Ratio1.781.87113.4543
Pretty Stable
Asset Turnover0.380.73270.4462
Slightly volatile

Evolent Health Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap772.9 M765.9 M698.1 M
Very volatile
Enterprise Value742.8 M749.4 M669.3 M
Slightly volatile

Evolent Fundamental Market Drivers

Forward Price Earnings10.4167
Cash And Short Term Investments192.8 M

Evolent Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Evolent Health Financial Statements

Investors use fundamental indicators, such as Evolent Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Evolent Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue6 M5.7 M
Total Revenue2 B2.1 B
Cost Of Revenue1.5 B1.6 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.28  0.55 
Research And Ddevelopement To Revenue 0.02  0.04 
Capex To Revenue 0.01  0.01 
Revenue Per Share 17.65  16.77 
Ebit Per Revenue(0.04)(0.04)

Currently Active Assets on Macroaxis

RSIRush Street Interactive
OKTAOkta Inc
BACBank of America
SSentinelOne
WDWalker Dunlop
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:
How To Invest In Evolent
Details
Is Evolent Stock a good investment?
Details
What is Evolent Health's Net Worth?
Details
Largest Health Care Technology Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Evolent Health Correlation against competitors.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.92)
Revenue Per Share
21.554
Quarterly Revenue Growth
0.216
Return On Assets
0.0073
Return On Equity
(0.06)
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY